1. Research Framework
1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation
2. Research Methodology
2.1. Qualitative Research
2.1.1. Primary & Secondary Research
2.2. Quantitative Research
2.3. Market Breakdown & Data Triangulation
2.3.1. Secondary Research
2.3.2. Primary Research
2.4. Breakdown of Primary Research Respondents, By Region
2.5. Assumption & Limitation
3. Executive Summary
4. Global Liquid Biopsy Market Insights
4.1. Industry Value Chain Analysis
4.2. DROC Analysis
4.2.1. Growth Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. Technological Advancement/Recent Development
4.4. Regulatory Framework
4.5. Porters Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Intensity of Rivalry
5. Global Liquid Biopsy Market Overview
5.1. Market Size & Forecast by Value, 2018-2028
5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
5.2.1. By Sampling Type
5.2.1.1. Blood Sampling
5.2.1.2. Urine Sampling
5.2.1.3. Saliva Sampling
5.2.1.4. Other Tissue Fluids Sampling
5.2.2. By Product and Service
5.2.2.1. Assay Kits
5.2.2.2. Instruments
5.2.2.3. Services
5.2.3. By Circulating Biomarker
5.2.3.1. Circulating Tumor Cells
5.2.3.2. Circulating Tumor DNA
5.2.4. By Clinical Application
5.2.4.1. Early Cancer Screening
5.2.4.2. Therapy Selection
5.2.4.3. Treatment Monitoring
5.2.4.4. Recurrence Monitoring
5.2.5. By Application
5.2.5.1. Cancer Applications
5.2.5.2. Non-Cancer Applications
5.2.6. By End User
5.2.6.1. Reference Laboratories
5.2.6.2. Hospitals
5.2.6.3. Physician Laboratories
5.2.6.4. Academic Researchers
5.2.6.5. Others
5.2.7. By Region
5.2.7.1. North America
5.2.7.2. Europe
5.2.7.3. The Asia Pacific
5.2.7.4. Latin America
5.2.7.5. The Middle East and Africa
6. North America Liquid Biopsy Market
6.1. Market Size & Forecast by Value, 2018-2028
6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
6.2.1. By Sampling Type
6.2.2. By Product and Service
6.2.3. By Circulating Biomarker
6.2.4. By Application
6.2.5. By Clinical Application
6.2.6. By End User
6.2.7. By Country
6.2.7.1. United States
6.2.7.2. Canada
7. Europe Liquid Biopsy Market
7.1. Market Size & Forecast by Value, 2018-2028
7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
7.2.1. By Sampling Type
7.2.2. By Product and Service
7.2.3. By Circulating Biomarker
7.2.4. By Application
7.2.5. By Clinical Application
7.2.6. By End User
7.2.7. By Country
7.2.7.1. Germany
7.2.7.2. United Kingdom
7.2.7.3. Italy
7.2.7.4. France
7.2.7.5. Spain
7.2.7.6. Rest of Europe
8. The Asia Pacific Liquid Biopsy Market
8.1. Market Size & Forecast by Value, 2018-2028
8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
8.2.1. By Sampling Type
8.2.2. By Product and Service
8.2.3. By Circulating Biomarker
8.2.4. By Application
8.2.5. By Clinical Application
8.2.6. By End User
8.2.7. By Country
8.2.7.1. China
8.2.7.2. India
8.2.7.3. Japan
8.2.7.4. South Korea
8.2.7.5. Rest of Asia Pacific
9. Latin America Liquid Biopsy Market
9.1. Market Size & Forecast by Value, 2018-2028
9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
9.2.1. By Sampling Type
9.2.2. By Product and Service
9.2.3. By Circulating Biomarker
9.2.4. By Application
9.2.5. By Clinical Application
9.2.6. By End User
9.2.7. By Country
9.2.7.1. Brazil
9.2.7.2. Mexico
9.2.7.3. Rest of Latin America
10. The Middle East & Africa Liquid Biopsy Market
10.1. Market Size & Forecast by Value, 2018-2028
10.1.1. By Value (USD Million)
10.2. Market Share & Forecast
10.2.1. By Sampling Type
10.2.2. By Product and Service
10.2.3. By Circulating Biomarker
10.2.4. By Application
10.2.5. By Clinical Application
10.2.6. By End User
10.2.7. By Country
10.2.7.1. Saudi Arabia
10.2.7.2. UAE
10.2.7.3. South Africa
10.2.7.4. Rest of Middle East & Africa
11. Competitive Landscape
11.1. List of Key Players and Their Offerings
11.2. Market Share Analysis, 2021
11.3. Competitive Benchmarking, By Operating Parameters
11.4. Key Strategic Development (Merger, Acquisition, Partnership, etc.)
12. Impact of Covid-19 on Global Liquid Biopsy Industry
13. Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook) **
13.1. F. Hoffmann-La Roche Ltd
13.2. Myraid Genetics
13.3. QIAGEN
13.4. Thermo Fisher Scientific Inc
13.5. Guardant Health
13.6. MDxHealth SA
13.7. Exact Sciences Corporation
13.8. Sysmex Inostics
13.9. Bio-Rad Laboratories
13.10. ANGLE plc
13.11. Other Prominent Players
14. Key Strategic Recommendations
*Financial information in case of non-listed companies will be provided as per availability
**The segmentation and the companies are subjected to modifications based on in-depth secondary for the final deliverable